Work

BH3 profiling as a predictive biomarker for response to cytarabine-based treatment of acute myelogenous leukemia.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.7022

Authors: William E. Pierceall, Nicole E. Carlson, David J. Richard, Xuelin Huang, Michael Elaschoff, Marina Konopleva, Steven Mitchell Kornblau, Michael H. Cardone, Michael Andreeff

Institutions: Eutropics Pharmaceuticals (United States), The University of Texas MD Anderson Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2598749276

Cites:

Cited by:

Related to: 10